Here, we observed increased levels of HER2, HER3 and HER4 in ER+ HER2 non-amplified tumours compared to normal tissue, implying a role of these receptors in HER2 non-amplified breast cancer [39]. This evidence concerns the gene ERBB3 and breast carcinoma.